- Home
- SAGE vs MNRO Comparison
SAGE vs MNRO Comparison
Compare SAGE & MNRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAGE
- MNRO
- Stock Information
- Founded
- SAGE 2010
- MNRO 1957
- Country
- SAGE United States
- MNRO United States
- Employees
- SAGE N/A
- MNRO N/A
- Industry
- SAGE Biotechnology: Pharmaceutical Preparations
- MNRO Automotive Aftermarket
- Sector
- SAGE Health Care
- MNRO Consumer Discretionary
- Exchange
- SAGE Nasdaq
- MNRO Nasdaq
- Market Cap
- SAGE 571.7M
- MNRO 658.9M
- IPO Year
- SAGE 2014
- MNRO 1991
- Fundamental
- Price
- SAGE $9.08
- MNRO $16.64
- Analyst Decision
- SAGE Hold
- MNRO Buy
- Analyst Count
- SAGE 18
- MNRO 4
- Target Price
- SAGE $10.06
- MNRO $21.00
- AVG Volume (30 Days)
- SAGE 2.8M
- MNRO 866.4K
- Earning Date
- SAGE 07-30-2025
- MNRO 07-30-2025
- Dividend Yield
- SAGE N/A
- MNRO 6.74%
- EPS Growth
- SAGE N/A
- MNRO N/A
- EPS
- SAGE N/A
- MNRO N/A
- Revenue
- SAGE $47,404,000.00
- MNRO $1,195,334,000.00
- Revenue This Year
- SAGE $102.21
- MNRO $0.31
- Revenue Next Year
- SAGE $43.01
- MNRO $2.42
- P/E Ratio
- SAGE N/A
- MNRO N/A
- Revenue Growth
- SAGE N/A
- MNRO N/A
- 52 Week Low
- SAGE $4.62
- MNRO $12.20
- 52 Week High
- SAGE $13.47
- MNRO $31.49
- Technical
- Relative Strength Index (RSI)
- SAGE 71.54
- MNRO 62.44
- Support Level
- SAGE $9.04
- MNRO $13.51
- Resistance Level
- SAGE $9.30
- MNRO $15.00
- Average True Range (ATR)
- SAGE 0.15
- MNRO 0.73
- MACD
- SAGE 0.05
- MNRO 0.12
- Stochastic Oscillator
- SAGE 91.35
- MNRO 99.52
About SAGE Sage Therapeutics Inc.
Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.
About MNRO Monro Inc.
Monro Inc is a provider automobile service stations in the United States. Through its network of company-owned service stations, Monro Muffler Brake offers maintenance, repair, tire, and fleet management services for automobiles focused largely on undercar services such as brake, steering, exhaust, drivetrain, and suspension systems. Next to service stores, the company also offers tire stores specialised in tire replacement and service.